Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 6519

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act regarding the patient medication information required to be included in the labeling of prescription drugs, and for other purposes.
About This Bill
Committee
Latest Action · January 31, 2022
Referred to the Subcommittee on Health.
Congress
117th (2021–2023)
Introduced
January 28, 2022
Cosponsors (10)
5D 5R
View PDF ↗

Summary

Highlight any text to annotate
Patients' Right to Know Their Medication Act of 2022 This bill requires the Food and Drug Administration (FDA) to issue regulations concerning the patient medication information that is included in the labeling for prescription medications. The regulations must impose various requirements, such as requiring the information to (1) be scientifically accurate and approved by the FDA; (2) include general directions for proper use and warnings that are written in understandable plain language; (3) contain information about known clinically important interactions with drugs, food, and other substances; (4) include a statement of whether there is sufficient data about the drug's use by specified subpopulations, such as children or pregnant women; and (5) be provided in a printed format with each prescription dispensed. The bill prohibits prescription medications that fail to meet this bill's requirements.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.